Zobrazeno 1 - 10
of 37
pro vyhledávání: '"MESH : Precursor Cell Lymphoblastic Leukemia-Lymphoma"'
Autor:
Bijal D. Shah, Armin Ghobadi, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Ryan D. Cassaday, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Dimitrios Tzachanis, Kristen M. O’Dwyer, Martha L. Arellano, Yi Lin, Maria R. Baer, Gary J. Schiller, Jae H. Park, Marion Subklewe, Mehrdad Abedi, Monique C. Minnema, William G. Wierda, Daniel J. DeAngelo, Patrick Stiff, Deepa Jeyakumar, Jinghui Dong, Sabina Adhikary, Lang Zhou, Petra C. Schuberth, Imi Faghmous, Behzad Kharabi Masouleh, Roch Houot
Publikováno v:
Journal of hematology & oncology, vol 15, iss 1
Journal of Hematology and Oncology
Journal of Hematology and Oncology, 2022, 15 (1), pp.170. ⟨10.1186/s13045-022-01379-0⟩
Journal of Hematology and Oncology
Journal of Hematology and Oncology, 2022, 15 (1), pp.170. ⟨10.1186/s13045-022-01379-0⟩
Background Brexucabtagene autoleucel (KTE-X19) is an autologous anti-CD19 CAR T-cell therapy approved in the USA to treat adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (R/R B-ALL) based on ZUMA-3 study results. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e535f707491b52d5e9e38e372d3320
https://pubmed.ncbi.nlm.nih.gov/36494725
https://pubmed.ncbi.nlm.nih.gov/36494725
Autor:
Marie-Therese Rubio, Roberta Di Blasi, Gilles Salles, Miguel A Perales, Kada Klouche, Muriel Picard, Pierre Sesques, Eric Mariotte, Michael Darmon, Boris Böll, Philippe R. Bauer, Sanjay Chawla, Kevin Rakszawski, Nahema Issa, Anne Huynh, Guillaume Cartron, Florence Rabian, Peter Borchmann, Michael Joannidis, Sabine Furst, Sophie de Guibert, Lara Zafrani, Patrice Ceballos, Nicolas Boissel, David Beauvais, Catherine Thieblemont, François-Xavier Gros, Alberto Mussetti, Gabriel Moreno-González, Adel Maamar, Florent Wallet, Faezeh Legrand, Julien Leroy, Quentin Quelven, Djamel Mokart, Valentin Ortiz, Christian Recher, Jakob Rudzki, Laura Platon, Pleun Hemelaar, Benoit Tessoulin, Reuben Benjamin, Sandrine Valade, Pedro Castro, Gennadii Galstian, Amélie Seguin, Peter Schellongowski, Anna Sureda, Alice Gallo De Moraes, Philipp Wohlfarth, Bruno Levy, Andry Van de Louw, Jorge Garcia Borrega, Julio Delgado, Ibrahim Yakoub-Agha, Nathalie Fégueux, Laveena Munshi, Yi Lin, Emmanuel Bachy, Stéphanie Harel, Sara Fernández, Bertrand Arnulf, Thomas Gastinne, Elie Azoulay, Didier Blaise, Amandine Le Bourgeois, Louis Voigt, Cécile Borel, Anne-Sophie Moreau, Christian Chabannon, Ulrich Jäger, Virginie Lemiale, Olga Gavrilina, Victoria Metaxa, Thomas Staudingert, Edouard Forcade
Publikováno v:
The Lancet Haematology
The Lancet Haematology, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
The Lancet Haematology, Elsevier, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
Lancet Haematology, 8, E355-E364
Dipòsit Digital de la UB
Universidad de Barcelona
Lancet Haematology, 8, 5, pp. E355-E364
The Lancet Haematology, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
The Lancet Haematology, Elsevier, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
Lancet Haematology, 8, E355-E364
Dipòsit Digital de la UB
Universidad de Barcelona
Lancet Haematology, 8, 5, pp. E355-E364
Summary Background Chimeric antigen receptor (CAR) T-cell therapy can induce side-effects such as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome (ICANS), which often require intensive care unit admission. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e0221bac10970ab09383fbb48e5504
https://hdl.handle.net/2066/241124
https://hdl.handle.net/2066/241124
Autor:
Audrey Grain, Fanny Rialland, Patrice Chevallier, Nicolas Blin, Jean-Hugues Dalle, Gérard Michel, Nathalie Dhédin, Régis Peffault de Latour, Cécile Pochon, Ibrahim Yakoub-Agha, Yves Bertrand, Anne Sirvent, Charlotte Jubert, Edouard Forcade, Ana Berceanu, Virginie Gandemer, Pascale Schneider, Jacques-Olivier Bay, Pierre-Simon Rohrlich, Eolia Brissot, Catherine Paillard, Dominique Plantaz, Stéphanie Nguyen Quoc, Fanny Gonzales, Natacha Maillard, Lucie Planche, Andre Baruchel
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 2022, 149 (4), pp.1473-1483. ⟨10.1007/s00432-022-04021-1⟩
Journal of Cancer Research and Clinical Oncology, 2022, 149 (4), pp.1473-1483. ⟨10.1007/s00432-022-04021-1⟩
International audience; Purpose: In the acute lymphoblastic leukemia (ALL) landscape, adolescents and young adults (AYA) often present high-risk diseases and increased chemotherapy-related toxicity. Studies analyzing the outcomes of AYA after hematop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6e014e89556487f51595997b01cf08
https://pubmed.ncbi.nlm.nih.gov/35507103
https://pubmed.ncbi.nlm.nih.gov/35507103
Autor:
Jérémie Rouger-Gaudichon, Yves Bertrand, Nicolas Boissel, Benoit Brethon, Stéphane Ducassou, Virginie Gandemer, Carine Halfon-Domenech, Thierry Leblanc, Guy Leverger, Gérard Michel, Arnaud Petit, Anne-France Ray-Lunven, Pierre-Simon Rohrlich, Pascale Schneider, Nicolas Sirvent, Marion Strullu, André Baruchel
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2021, 108 (5), pp.490-500. ⟨10.1016/j.bulcan.2021.02.004⟩
Bulletin du Cancer, 2021, 108 (5), pp.490-500. ⟨10.1016/j.bulcan.2021.02.004⟩
Depuis l’émergence de l’infection à SARS-CoV-2, de très nombreuses recommandations ont été émises. Cependant la nature de la maladie et la spécificité du traitement des leucémies aiguës lymphoblastiques de l’enfant et de l’adolescen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27e77e99033d737d9e0374c1e4947a23
http://europepmc.org/articles/PMC7951944
http://europepmc.org/articles/PMC7951944
Autor:
Yves Bertrand, Pierre-Simon Rohrlich, Laura Olivier-Gougenheim, Hélène Cavé, Barbara De Moerloose, Anne Uyttebroeck, Alina Ferster, Stefan Suciu, Carine Domenech, Chloé Arfeuille, Geneviève Plat, N Sirvent
Publikováno v:
Hematological Oncology
Hematological Oncology, Wiley, 2020, 38 (5), pp.763-772. ⟨10.1002/hon.2791⟩
Hematological Oncology, Wiley, 2020, 38 (5), pp.763-772. ⟨10.1002/hon.2791⟩
International audience; Over the years, the prognosis of adolescents treated for acute lymphoblastic leukemia (ALL) has improved. However, this age group still represents a challenge with an overall survival (OS) of 60% compared to 85% in younger chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a2034481de8f5c1f968b7438a060cc
https://hal.umontpellier.fr/hal-03359668
https://hal.umontpellier.fr/hal-03359668
Autor:
Catherine Paillard, Virginie Gandemer, Camille Vercasson, Maryline Poiree, André Baruchel, Sophie Ansoborlo, Sandrine Thouvenin-Doulet, Audrey Contet, Nicolas Sirvent, Julie Berbis, Jean-Hugues Dalle, Justyna Kanold, Zeinab Hamidou, Pascal Auquier, Claire Freycon, Marie-Dominique Tabone, Gérard Michel, Guy Leverger, Yves Bertrand
Publikováno v:
Pediatric Blood and Cancer
Pediatric Blood and Cancer, Wiley, 2020, 67 (10), pp.e28419. ⟨10.1002/pbc.28419⟩
Pediatric Blood and Cancer, 2020, 67 (10), pp.e28419. ⟨10.1002/pbc.28419⟩
Pediatric Blood and Cancer, Wiley, 2020, 67 (10), pp.e28419. ⟨10.1002/pbc.28419⟩
Pediatric Blood and Cancer, 2020, 67 (10), pp.e28419. ⟨10.1002/pbc.28419⟩
International audience; Introduction: Our objectives were to assess the quality of life (QoL) of parents of childhood leukemia survivors compared with population norms and to identify the determinants of parents' long-term QoL.Methods: Parents of min
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::364e06e8e9da14ced1b65e5b3eb3c466
https://pubmed.ncbi.nlm.nih.gov/32798263
https://pubmed.ncbi.nlm.nih.gov/32798263
Autor:
Colette Raffoux, Mohamad Mohty, R. Tabrizi, J.Y. Cahn, Ibrahim Yakoub-Agha, J. H. Bourhis, Yosr Hicheri, Norbert Ifrah, Mauricette Michallet, Agnès Buzyn, Nathalie Dhedin, Myriam Labopin, Marie-Lorraine Balere, Didier Blaise, Gérard Socié, Helene Esperou, Noel Milpied
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1867-74. ⟨10.1038/leu.2010.200⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1867-74. 〈10.1038/leu.2010.200〉
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1867-74. ⟨10.1038/leu.2010.200⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2010, 24 (11), pp.1867-74. 〈10.1038/leu.2010.200〉
International audience; This retrospective report assessed the impact of rabbit antithymocyte globulins (ATG), incorporated within a standard myeloablative conditioning regimen prior to allogeneic stem cell transplantation (allo-SCT) using human leuk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2051648fc8115d4e338da5ef892233f1
https://doi.org/10.1038/leu.2010.200
https://doi.org/10.1038/leu.2010.200
Autor:
Bianca Balbino, George Delidakis, Tae Hyun Kang, Makiko Watanabe, Kendra Triplett, Anja Lux, Navin Varadarajan, Odile Richard-Le Goff, Oana I. Lungu, Pierre Bruhns, George Georgiou, Corrine Alford, Gabrielle Romain, Margaret A. Lindorfer, Wissam Charab, Falk Nimmerjahn, Yan Jessie Zhang, Hidetaka Tanno, Wupeng Yan, Nicholas M. Marshall, Moses Donkor, Chang-Han Lee, Jiwon Lee, Ronald P. Taylor, Biliana Todorova
Publikováno v:
Nature Immunology
Nature Immunology, Nature Publishing Group, 2017, 18 (8), pp.889-898. ⟨10.1038/ni.3770⟩
Nature Immunology, 2017, 18 (8), pp.889-898. ⟨10.1038/ni.3770⟩
Nature Immunology, Nature Publishing Group, 2017, 18 (8), pp.889-898. ⟨10.1038/ni.3770⟩
Nature Immunology, 2017, 18 (8), pp.889-898. ⟨10.1038/ni.3770⟩
International audience; Engineered crystallizable fragment (Fc) regions of antibody domains, which assume a unique and unprecedented asymmetric structure within the homodimeric Fc polypeptide, enable completely selective binding to the complement com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d0740466da17325dc05af13c9b0b13
https://hal-pasteur.archives-ouvertes.fr/pasteur-02510289
https://hal-pasteur.archives-ouvertes.fr/pasteur-02510289
Autor:
Anne Thiebaut-Bertrand, Sylvie Larrat, N Sturm, Sébastien Lhomme, Vincent Leroy, Martin Carre, J. Y. Cahn, Frédéric Garban, Patricia Pouzol, Patrice Morand
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2017, 52 (4), pp.643-645. ⟨10.1038/bmt.2016.337⟩
Bone Marrow Transplantation, 2017, 52 (4), pp.643-645. ⟨10.1038/bmt.2016.337⟩
Bone Marrow Transplantation, Nature Publishing Group, 2017, 52 (4), pp.643-645. ⟨10.1038/bmt.2016.337⟩
Bone Marrow Transplantation, 2017, 52 (4), pp.643-645. ⟨10.1038/bmt.2016.337⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c349a349db5a7b50bc3d5ce07cc24e0d
https://pubmed.ncbi.nlm.nih.gov/28067868
https://pubmed.ncbi.nlm.nih.gov/28067868
Autor:
Claudine Schmitt, Marie-Françoise Auclerc, Jean-Michel Cayuela, Gérard Michel, André Baruchel, Guy Leverger, Marianne Debré, Yves Perel, Brigitte Pautard, Thierry Leblanc, Gérard Socié, Raphaël Porcher, Caroline Oudot, Christophe Piguet, Virginie Gandemer, Vincent Levy, Claire Berger, Christiane Vermylen
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. 〈10.1200/JCO.2007.12.2820〉
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. 〈10.1200/JCO.2007.12.2820〉
Purpose To identify prognostic factors and to evaluate the outcome of children with acute lymphoblastic leukemia (ALL) failure after induction therapy. Patients and Methods Between June 1993 and December 1999, 1,395 leukemic children were included in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a4a147552ddeb2bd5ffdfcf748dc8f4
https://doi.org/10.1200/jco.2007.12.2820
https://doi.org/10.1200/jco.2007.12.2820